[go: up one dir, main page]

ES2118333T3 - Derivados del acido naftilacetico como agonistas y antagonistas de pgez. - Google Patents

Derivados del acido naftilacetico como agonistas y antagonistas de pgez.

Info

Publication number
ES2118333T3
ES2118333T3 ES94309088T ES94309088T ES2118333T3 ES 2118333 T3 ES2118333 T3 ES 2118333T3 ES 94309088 T ES94309088 T ES 94309088T ES 94309088 T ES94309088 T ES 94309088T ES 2118333 T3 ES2118333 T3 ES 2118333T3
Authority
ES
Spain
Prior art keywords
agonists
derivatives
acid
naphtilacetic
pgez
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES94309088T
Other languages
English (en)
Inventor
Yuuki Nagao
Takayuki Maruyama
Hamanaka Nobuyuki
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ono Pharmaceutical Co Ltd
Original Assignee
Ono Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ono Pharmaceutical Co Ltd filed Critical Ono Pharmaceutical Co Ltd
Application granted granted Critical
Publication of ES2118333T3 publication Critical patent/ES2118333T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
    • C07C311/22—Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound oxygen atoms
    • C07C311/23—Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound oxygen atoms having the sulfur atoms of the sulfonamide groups bound to acyclic carbon atoms
    • C07C311/25—Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound oxygen atoms having the sulfur atoms of the sulfonamide groups bound to acyclic carbon atoms of a saturated carbon skeleton containing rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
    • C07C311/01—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms
    • C07C311/12—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms of an unsaturated carbon skeleton containing rings
    • C07C311/13—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms of an unsaturated carbon skeleton containing rings the carbon skeleton containing six-membered aromatic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/18—Sulfonamides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
    • C07C311/01—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms
    • C07C311/02—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton
    • C07C311/08—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton having the nitrogen atom of at least one of the sulfonamide groups bound to a carbon atom of a six-membered aromatic ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
    • C07C311/15—Sulfonamides having sulfur atoms of sulfonamide groups bound to carbon atoms of six-membered aromatic rings
    • C07C311/20—Sulfonamides having sulfur atoms of sulfonamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the sulfonamide groups bound to a carbon atom of a ring other than a six-membered aromatic ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
    • C07C311/22—Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound oxygen atoms
    • C07C311/23—Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound oxygen atoms having the sulfur atoms of the sulfonamide groups bound to acyclic carbon atoms
    • C07C311/27—Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound oxygen atoms having the sulfur atoms of the sulfonamide groups bound to acyclic carbon atoms of an unsaturated carbon skeleton containing rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
    • C07C311/22—Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound oxygen atoms
    • C07C311/28—Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound oxygen atoms having the sulfur atom of at least one of the sulfonamide groups bound to a carbon atom of a ring other than a six-membered aromatic ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
    • C07C311/22—Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound oxygen atoms
    • C07C311/29—Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound oxygen atoms having the sulfur atom of at least one of the sulfonamide groups bound to a carbon atom of a six-membered aromatic ring

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Peptides Or Proteins (AREA)

Abstract

DERIVADOS DE ACIDO NAFTILOXIACETICO DE FORMULA (I) ESPECIFICADA, DONDE R1 REPRESENTA CARBOXILO O ALCOXICARBONILO, CARBAMOILO OPCIONALMENTE SUSTITUIDO POR ALQUILO O HIDROXIALQUILO O HIDROXIMETILO; EL GRUPO A REPRESENTA UN ENLACE O UN GRUPO ALQUILENO C1-4 O PUEDE, EN UNION A LOS ATOMOS DE CARBONO DE LAS POSICIONES ADYACENTES DONDE ESTA VINCULADO, REPRESENTAR UN ANILLO DE 5, 6 O 7 ELEMENTOS; B REPRESENTA UN GRUPO -NR3SO2- O -SO2NR3EN EL QUE R3 ES HIDROGENO, ALQUILO O CH2COOR7 DONDE R7 ES HIDROGENO O ALQUILO; R2 ES ALQUILO, ALQUENILO O ALQUINILO OPCIONALMENTE SUSTITUIDO POR FENILO O CICLOALQUILO O R2 REPRESENTA NAFTILO; Y SUS SALES SON ANTOGONISTAS DE PGE2 O AGONISTAS.
ES94309088T 1993-12-09 1994-12-07 Derivados del acido naftilacetico como agonistas y antagonistas de pgez. Expired - Lifetime ES2118333T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP34085493 1993-12-09

Publications (1)

Publication Number Publication Date
ES2118333T3 true ES2118333T3 (es) 1998-09-16

Family

ID=18340925

Family Applications (1)

Application Number Title Priority Date Filing Date
ES94309088T Expired - Lifetime ES2118333T3 (es) 1993-12-09 1994-12-07 Derivados del acido naftilacetico como agonistas y antagonistas de pgez.

Country Status (10)

Country Link
US (2) US5624959A (es)
EP (1) EP0657422B1 (es)
KR (1) KR100191946B1 (es)
CN (1) CN1111612A (es)
AT (1) ATE167181T1 (es)
CA (1) CA2137711A1 (es)
DE (1) DE69410956T2 (es)
DK (1) DK0657422T3 (es)
ES (1) ES2118333T3 (es)
GR (1) GR3027694T3 (es)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3909864B2 (ja) * 1995-07-26 2007-04-25 小野薬品工業株式会社 ナフチルオキシ酢酸誘導体およびそれらを有効成分として含有する薬剤
US6197993B1 (en) 1996-07-02 2001-03-06 Ono Pharmaceutical Co., Ltd. Naphthyloxyacetic acid derivatives and a pharmaceutical composition comprising them as an active ingredient
GB9702194D0 (en) 1997-02-04 1997-03-26 Lilly Co Eli Sulphonide derivatives
AU8750298A (en) * 1997-08-28 1999-03-22 Ono Pharmaceutical Co. Ltd. Peroxisome proliferator-activated receptor controllers
CA2322139A1 (en) 1998-02-24 1999-09-02 Eli Lilly And Company Sulphonamide derivatives
EP1177187B1 (en) 1999-04-28 2007-07-25 Sanofi-Aventis Deutschland GmbH Di-aryl acid derivatives as ppar receptor ligands
GB0124124D0 (en) * 2001-10-08 2001-11-28 Medical Res Council Methods of treatment
EP1563845A4 (en) * 2002-10-10 2008-02-20 Univ Kyoto REMEDIES FOR ALLERGIC DISEASES
US8765812B2 (en) * 2006-07-05 2014-07-01 Fibrotech Therapeutics Pty Ltd Therapeutic compounds
DE102007013855A1 (de) 2007-03-20 2008-09-25 Merck Patent Gmbh Substituierte Tetrahydrochinoline
US20080265343A1 (en) * 2007-04-26 2008-10-30 International Business Machines Corporation Field effect transistor with inverted t shaped gate electrode and methods for fabrication thereof
NZ584613A (en) * 2007-12-21 2011-07-29 Fibrotech Therapeutics Pty Ltd Halogenated cinnamoylbenzamide derivatives for anti-fibrotic drugs
CA2732210A1 (en) * 2008-08-15 2010-02-18 F. Hoffmann-La Roche Ag Monoaryl aminotetralines
EP2321268A2 (en) 2008-08-15 2011-05-18 F. Hoffmann-La Roche AG Bi-aryl aminotetralines
CA2734104A1 (en) * 2008-08-15 2010-02-18 F. Hoffmann-La Roche Ag Substituted aminotetralines
CN102216273A (zh) 2008-11-17 2011-10-12 霍夫曼-拉罗奇有限公司 用作crth2拮抗剂或部分激动剂的萘乙酸
US8642629B2 (en) 2008-11-17 2014-02-04 Hoffmann-La Roche Inc. Naphthylacetic acids
KR20110071122A (ko) 2008-11-17 2011-06-28 에프. 호프만-라 로슈 아게 나프틸아세트산
IN2012DN03312A (es) 2009-10-22 2015-10-23 Fibrotech Therapeutics Pty Ltd
US8470884B2 (en) 2011-11-09 2013-06-25 Hoffmann-La Roche Inc. Alkenyl naphthylacetic acids
CN102964279B (zh) * 2012-12-12 2014-05-07 中国药科大学 一类具有外周镇痛作用的κ阿片受体激动剂

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3623941A1 (de) * 1986-07-16 1988-01-28 Bayer Ag Substituierte amino-5,6,7,8-tetrahydronaphthyl-oxyessigsaeuren, verfahren zu deren herstellung sowie die verwendung als arzneimittel
DE3642105A1 (de) * 1986-12-10 1988-06-16 Bayer Ag Substituierte aminomethyl-5,6,7,8-tetrahydronaphtyl-oxyessigsaeuren, neue zwischenprodukte, verfahren zu ihrer herstellung sowie ihre verwendung in arzneimitteln

Also Published As

Publication number Publication date
EP0657422A1 (en) 1995-06-14
EP0657422B1 (en) 1998-06-10
US5624959A (en) 1997-04-29
CA2137711A1 (en) 1995-06-10
ATE167181T1 (de) 1998-06-15
GR3027694T3 (en) 1998-11-30
CN1111612A (zh) 1995-11-15
DK0657422T3 (da) 1998-10-12
DE69410956T2 (de) 1999-03-25
KR950017941A (ko) 1995-07-22
US5723493A (en) 1998-03-03
DE69410956D1 (de) 1998-07-16
KR100191946B1 (ko) 1999-06-15

Similar Documents

Publication Publication Date Title
ES2118333T3 (es) Derivados del acido naftilacetico como agonistas y antagonistas de pgez.
ES2044934T3 (es) Derivados de acido fenil-sustituido-2-propenoicos de utilidad en agricultura.
ES2097872T3 (es) Fenilpirazolidinonas como agentes broncodilatadores y antiinflamatorios.
ES2033840T3 (es) P-aminoetilsulfonanilidas n-sustituidas como agentes antiarritmicos; e intermedios para los mismos.
ES2036551T3 (es) Compuestos heterociclicos.
ES2055056T3 (es) Derivados de pirimidopirimidina.
AR008377A1 (es) Un compuesto derivado de la 3-aroilbencilpiridazinona, una composicion farmaceutica particularmente para el tratamiento de enfermedades inflamatorias o autoinmunes que contiene dicho compuesto
ES2194835T3 (es) Agentes antitromboticos a base de tripeptidos.
PA8463501A1 (es) Derivados de acido hidroxamico como inhibidores de metaloproteasas de matriz (mmp)
AR036114A1 (es) Tetrahidroimidazol[1,2-a]pirazinas y tetrahidrotriazol[4,3-a]pirazinas como inhibidores de la dipeptidil peptidasa utiles para el tratamiento o la prevencion de la diabetes
ES2160237T3 (es) O-carbamoil-fenilalaninol que tiene sustituyente en anillo de benceno, sus sales farmaceuticamente utiles, y metodo para la preparacion de los mismos.
ES2051772T3 (es) 2-sustituido-e-fusionado-(1,2,4)-triazol(1,5-c)pirimidinas, composiciones farmaceuticas y sus usos.
ES2143487T3 (es) 1,2,4-oxadiazolil-fenoxialquilisoxazoles y su empleo como agentes antivirales.
ES2065324T3 (es) N-(piridinil)-1h-indol-1-aminas, un procedimiento para su preparacion y su uso como medicamentos.
ES2002031A6 (es) Procedimiento para preparar 4,4'-metilen-bis-(meta-cloro-2,6-dialquilanilinas)
ES2036213T3 (es) Procedimiento para preparar derivados tetrahidroisoquinolin-1-ilicos de acidos carboxilicos.
ES2040879T3 (es) Procedimiento de preparacion de derivados pirimidinilaminicos de piperidina.
ES2069281T3 (es) Derivado de fenantreno.
MX174285B (es) Agente de conservacion para plantas
ES2081314T3 (es) Compuestos de diaminoetileno.
ES8307718A1 (es) "procedimiento de preparar amidoaminoacidos y similares".
ES2056073T3 (es) Aril-aralquil-eteres, procedimientos para su preparacion y composicion farmaceutica que los comprende.
ES2029879T3 (es) Procedimiento para producir derivados de aminas sustituidas.
ES8202001A1 (es) Procedimiento de producir dihidropiridinas n-morfolinoalqui-licas
ES2040856T3 (es) Un procedimiento para preparar un compuesto de tiofeno.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 657422

Country of ref document: ES